ArcelorMittal SA vs Tilray Brands Inc — how do they compare? ArcelorMittal SA trades at $64.3 (market cap $45.70B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: ArcelorMittal SA is far larger — about 86.1× Tilray Brands Inc's market cap, and ArcelorMittal SA pays a 0.98% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold ArcelorMittal SA for 36 Days and Tilray Brands Inc for 31 Days on average.
| MT | TLRY | |
|---|---|---|
Market Cap | $45.70B | $530.54M |
Volume | 1,964,621 | 9,099,075 |
Sector | Basic Materials | Health |
52-Week High | $78.74 | $21.00 |
52-Week Low | $36.91 | $3.57 |
Typical Hold Time | 36 Days | 31 Days |
Enterprise Value | $55.27B | $684.46M |
Dividend Yield | 0.98% | — |
Signals from Pluang's Aura AI — not financial advice
ArcelorMittal (MT) trades at $64.11, up 2.87% with mixed technical signals showing bearish moving averages but bullish oscillators. The company reported Q2 2026 earnings miss but maintains strong cash flow and operational momentum. Recent news highlights challenges from Ukraine plant disruptions with a $1 billion impairment charge, though strategic expansions and Microsoft partnership provide growth catalysts. Valuation remains attractive with P/S of 0.75 and P/B of 0.84.
Outlook remains cautiously optimistic with analyst consensus price target of $74.33 offering 16% upside. Key risks include geopolitical exposure in Ukraine, volatile steel demand, and elevated capital expenditures. The stock presents value opportunity given discounted valuations against sector peers, supported by improving European order books and shareholder returns through dividends.
Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.
The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →